Hall Benefits Law | USA | 15 Mar 2024
The Internal Revenue Service, Employee Benefits Security Administration, and the Centers for Medicare & Medicaid Services (collectively, "the…
Benesch Friedlander Coplan & Aronoff LLP | USA | 13 Mar 2024
It's 2024, and while nothing ever stays the same in the world of cannabis, in a lot of ways, 2024 feels just like 2023, and 2022. More states have…
Nelson Mullins Riley & Scarborough LLP | USA | 7 Mar 2024
The Georgia House of Representatives took up a veritable smorgasbord of legislation on Thursday. From the establishment of a license plate…
Akin Gump Strauss Hauer & Feld LLP | USA | 23 Feb 2024
The scientific review supporting HHS’s recommendation to DEA that cannabis be reclassified from a Schedule I to a Schedule III drug was…
Fenwick & West LLP | USA | 22 Feb 2024
In the constantly changing health insurance landscape, level-funded health plans are steadily gaining ground as a viable middle approach between…
Mintz | USA | 21 Feb 2024
On August 29, 2023, CMS selected the first 10 high-expenditure, single source, Medicare Part D drugs subject to negotiation under the IRA’s Medicare…
Nelson Mullins Riley & Scarborough LLP | USA | 13 Feb 2024
Amidst the madness of the legislative session, it is important to pause and appreciate the melting pot that is the Georgia General Assembly. For…
Burns & Levinson LLP | USA | 13 Feb 2024
As books for 2023 have officially been closed, we are looking forward to greener pastures in 2024. 2023 proved to be a difficult year for…
Proskauer Rose LLP | USA | 13 Feb 2024
In 2021, Congress enacted the Corporate Transparency Act (the “CTA”) to “better enable critical national security, intelligence, and law enforcement…
Baker McKenzie | USA | 9 Feb 2024
In the recent case of Soroban Capital Partners LP v. Commissioner, 161 T.C. No. 12 (2023), the Tax Court held that the limited partner exception…